CDKN2A and glaucoma: These epigenetic changes suppress the transcription of nearby tumour-suppressor genes CDKN2A and CDKN2B, thereby linking upstream signals to downstream cell cycle and stress response pathways relevant to both glaucoma and CVD [20,21].